S&P 500 7,666.45 +0.19%
Nasdaq 26,871.60 +0.04%
S&P/TSX 35,154.76 −0.23%
Apple 330.32 −0.81%
Nvidia 230.86 +1.09%
Microsoft 512.80 −0.02%
Shopify 212.10 +0.56%
Royal Bank 277.86 −0.74%
CAD/USD 0.7035 +0.15%
CLOSED · 01:05 ET
Market ClerkRecap
Fri Oct 2 · markets closed3 signals on Oct 1308 insider buys this week · $10330.5BCIRO short report next: Oct 14The week ahead
SA
INSIDER · RVMD · Revolution Medicines, Inc. · CHIEF DEVELOPMENT OFFICER

Sandler Alan B.

Every open-market transaction filed under this name, Sep 16 to Sep 29.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$1.3M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell301$204.72$62K+0.6%
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,199$203.91$244K+1.0%
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,000$202.81$203K+1.5%
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell1,609$201.72$325K+2.1%
Sep 29RVMDRevolution Medicines, Inc.Chief Development OfficerSell2,200$200.82$442K+2.5%
Sep 16RVMDRevolution Medicines, Inc.Chief Development OfficerSell336$199.30$67K+3.3%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.